

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.96365896 |
| 2 | ensheathment of neurons (GO:0007272) | 7.01375831 |
| 3 | axon ensheathment (GO:0008366) | 7.01375831 |
| 4 | myelination (GO:0042552) | 6.98318029 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.23844041 |
| 6 | myelin maintenance (GO:0043217) | 5.53664134 |
| 7 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.26053734 |
| 8 | negative regulation of neurotransmitter transport (GO:0051589) | 5.06663384 |
| 9 | cholesterol biosynthetic process (GO:0006695) | 4.74052154 |
| 10 | L-amino acid import (GO:0043092) | 4.67872610 |
| 11 | establishment of mitochondrion localization (GO:0051654) | 4.58304354 |
| 12 | negative regulation of protein localization to cell surface (GO:2000009) | 4.56353741 |
| 13 | regulation of collateral sprouting (GO:0048670) | 4.53789676 |
| 14 | oligodendrocyte differentiation (GO:0048709) | 4.46049648 |
| 15 | response to methylmercury (GO:0051597) | 4.41464210 |
| 16 | glycerophospholipid catabolic process (GO:0046475) | 4.34959729 |
| 17 | creatine metabolic process (GO:0006600) | 4.31936225 |
| 18 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.30550888 |
| 19 | sterol biosynthetic process (GO:0016126) | 4.24559791 |
| 20 | photoreceptor cell differentiation (GO:0046530) | 4.16965844 |
| 21 | eye photoreceptor cell differentiation (GO:0001754) | 4.16965844 |
| 22 | presynaptic membrane organization (GO:0097090) | 4.11912369 |
| 23 | amyloid precursor protein metabolic process (GO:0042982) | 4.03959697 |
| 24 | apical protein localization (GO:0045176) | 4.03583156 |
| 25 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.00599922 |
| 26 | astrocyte development (GO:0014002) | 3.99857881 |
| 27 | asymmetric protein localization (GO:0008105) | 3.98247805 |
| 28 | import into cell (GO:0098657) | 3.87233967 |
| 29 | isoprenoid biosynthetic process (GO:0008299) | 3.73838189 |
| 30 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.72682447 |
| 31 | substantia nigra development (GO:0021762) | 3.71019851 |
| 32 | presynaptic membrane assembly (GO:0097105) | 3.67501464 |
| 33 | response to redox state (GO:0051775) | 3.65226497 |
| 34 | membrane tubulation (GO:0097320) | 3.53675001 |
| 35 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.51232013 |
| 36 | regulation of lipoprotein metabolic process (GO:0050746) | 3.50386767 |
| 37 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.50042227 |
| 38 | response to lipoprotein particle (GO:0055094) | 3.46895463 |
| 39 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.45598256 |
| 40 | amino acid import (GO:0043090) | 3.43117760 |
| 41 | protein palmitoylation (GO:0018345) | 3.40586458 |
| 42 | GPI anchor biosynthetic process (GO:0006506) | 3.40235476 |
| 43 | adult walking behavior (GO:0007628) | 3.37426675 |
| 44 | magnesium ion transport (GO:0015693) | 3.35965331 |
| 45 | GPI anchor metabolic process (GO:0006505) | 3.33413663 |
| 46 | peripheral nervous system axon ensheathment (GO:0032292) | 3.30081127 |
| 47 | myelination in peripheral nervous system (GO:0022011) | 3.30081127 |
| 48 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.27687037 |
| 49 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.23933444 |
| 50 | neurotransmitter uptake (GO:0001504) | 3.22235304 |
| 51 | neuron remodeling (GO:0016322) | 3.20276223 |
| 52 | limb bud formation (GO:0060174) | 3.19099059 |
| 53 | axon development (GO:0061564) | 3.12887201 |
| 54 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.08047965 |
| 55 | very long-chain fatty acid metabolic process (GO:0000038) | 3.06617133 |
| 56 | negative regulation of axonogenesis (GO:0050771) | 3.02597494 |
| 57 | glycosylceramide metabolic process (GO:0006677) | 3.01419637 |
| 58 | adhesion of symbiont to host cell (GO:0044650) | 2.95987729 |
| 59 | virion attachment to host cell (GO:0019062) | 2.95987729 |
| 60 | neuron cell-cell adhesion (GO:0007158) | 2.92326030 |
| 61 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.87564980 |
| 62 | neuronal action potential propagation (GO:0019227) | 2.85350790 |
| 63 | positive regulation of glial cell differentiation (GO:0045687) | 2.85171575 |
| 64 | peptidyl-cysteine modification (GO:0018198) | 2.81879396 |
| 65 | organ growth (GO:0035265) | 2.81418064 |
| 66 | nerve growth factor signaling pathway (GO:0038180) | 2.81166677 |
| 67 | transmission of nerve impulse (GO:0019226) | 2.79753124 |
| 68 | amyloid precursor protein catabolic process (GO:0042987) | 2.77707599 |
| 69 | nucleotide transmembrane transport (GO:1901679) | 2.77563858 |
| 70 | negative regulation of JUN kinase activity (GO:0043508) | 2.76564123 |
| 71 | positive regulation of action potential (GO:0045760) | 2.73085809 |
| 72 | peripheral nervous system development (GO:0007422) | 2.72574744 |
| 73 | thioester biosynthetic process (GO:0035384) | 2.71780461 |
| 74 | acyl-CoA biosynthetic process (GO:0071616) | 2.71780461 |
| 75 | protein neddylation (GO:0045116) | 2.71549542 |
| 76 | enteric nervous system development (GO:0048484) | 2.68752633 |
| 77 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.67520840 |
| 78 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.67439293 |
| 79 | glial cell development (GO:0021782) | 2.66028083 |
| 80 | positive regulation of gliogenesis (GO:0014015) | 2.65862101 |
| 81 | response to lead ion (GO:0010288) | 2.65657477 |
| 82 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.65425986 |
| 83 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.63413265 |
| 84 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.63413265 |
| 85 | Golgi to endosome transport (GO:0006895) | 2.63276717 |
| 86 | cranial nerve development (GO:0021545) | 2.59261775 |
| 87 | cellular response to epinephrine stimulus (GO:0071872) | 2.59255947 |
| 88 | iron coordination entity transport (GO:1901678) | 2.58851064 |
| 89 | heme transport (GO:0015886) | 2.53373215 |
| 90 | neural nucleus development (GO:0048857) | 2.52535471 |
| 91 | microtubule polymerization or depolymerization (GO:0031109) | 2.51735946 |
| 92 | neuronal ion channel clustering (GO:0045161) | 2.50605626 |
| 93 | negative regulation of macroautophagy (GO:0016242) | 2.48479979 |
| 94 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.48256280 |
| 95 | L-phenylalanine catabolic process (GO:0006559) | 2.48256280 |
| 96 | regulation of dopamine metabolic process (GO:0042053) | 2.46153088 |
| 97 | regulation of catecholamine metabolic process (GO:0042069) | 2.46153088 |
| 98 | negative regulation of axon extension (GO:0030517) | 2.45827304 |
| 99 | central nervous system myelination (GO:0022010) | 12.7247653 |
| 100 | axon ensheathment in central nervous system (GO:0032291) | 12.7247653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.39938942 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.83450935 |
| 3 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.75812235 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.63914593 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.34122690 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33696753 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.31934529 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.22623684 |
| 9 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.13562451 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02102119 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00580647 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.99156796 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98441064 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.98334233 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.95049242 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.95005633 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.95005633 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90878450 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.89415612 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87328076 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85296715 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84549484 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.82875404 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.81749290 |
| 25 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76010930 |
| 26 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75959143 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72634246 |
| 28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.69848964 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68208047 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60052880 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58646100 |
| 32 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.57653042 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55199641 |
| 34 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.53178829 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.52891537 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48469698 |
| 37 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.47250515 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46357032 |
| 39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42217019 |
| 40 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40403462 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40239812 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39548324 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36017069 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34652904 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31766812 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29338704 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28305683 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27982651 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25484556 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23825021 |
| 51 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23553251 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23068455 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23068455 |
| 54 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22985820 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21959075 |
| 56 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17356309 |
| 57 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13880731 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13760703 |
| 59 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13707430 |
| 60 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12737822 |
| 61 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09787368 |
| 62 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08967151 |
| 63 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08821375 |
| 64 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08457661 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07455816 |
| 66 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.07216153 |
| 67 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06851000 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06656240 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04659937 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04362226 |
| 71 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03842630 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03362764 |
| 73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02975494 |
| 74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02388936 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00219551 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99919366 |
| 77 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99859500 |
| 78 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.99615050 |
| 79 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98481357 |
| 80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97707022 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97424848 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97170465 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97097784 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96836735 |
| 85 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96693039 |
| 86 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.95000305 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94935047 |
| 88 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94484429 |
| 89 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94364109 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94364109 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93695703 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93027305 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92861984 |
| 94 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.91823303 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89166820 |
| 96 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.88869638 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87863918 |
| 98 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86477168 |
| 99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86068698 |
| 100 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.85980206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.64006488 |
| 2 | MP0003880_abnormal_central_pattern | 3.88116010 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.70128688 |
| 4 | MP0003690_abnormal_glial_cell | 3.24128965 |
| 5 | MP0004270_analgesia | 3.21895204 |
| 6 | MP0001529_abnormal_vocalization | 2.90169698 |
| 7 | MP0003329_amyloid_beta_deposits | 2.77991723 |
| 8 | MP0004885_abnormal_endolymph | 2.74696683 |
| 9 | MP0004742_abnormal_vestibular_system | 2.63308680 |
| 10 | MP0005171_absent_coat_pigmentation | 2.63109492 |
| 11 | MP0003136_yellow_coat_color | 2.57659261 |
| 12 | MP0002272_abnormal_nervous_system | 2.56827845 |
| 13 | MP0001486_abnormal_startle_reflex | 2.52702121 |
| 14 | MP0004142_abnormal_muscle_tone | 2.44070942 |
| 15 | MP0001905_abnormal_dopamine_level | 2.41413052 |
| 16 | MP0003634_abnormal_glial_cell | 2.34926566 |
| 17 | MP0002064_seizures | 2.23896794 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.21668284 |
| 19 | MP0005409_darkened_coat_color | 2.16726603 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.15544337 |
| 21 | MP0000778_abnormal_nervous_system | 2.10707472 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 2.01784970 |
| 23 | MP0005410_abnormal_fertilization | 2.00090792 |
| 24 | MP0003632_abnormal_nervous_system | 1.88711085 |
| 25 | MP0002229_neurodegeneration | 1.88494394 |
| 26 | MP0010678_abnormal_skin_adnexa | 1.83856180 |
| 27 | MP0009046_muscle_twitch | 1.79849875 |
| 28 | MP0004043_abnormal_pH_regulation | 1.76359300 |
| 29 | MP0009745_abnormal_behavioral_response | 1.73728086 |
| 30 | MP0003635_abnormal_synaptic_transmissio | 1.73255617 |
| 31 | MP0005451_abnormal_body_composition | 1.67592373 |
| 32 | MP0000383_abnormal_hair_follicle | 1.64376989 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.61370661 |
| 34 | MP0004381_abnormal_hair_follicle | 1.60419351 |
| 35 | MP0000462_abnormal_digestive_system | 1.56942076 |
| 36 | MP0003631_nervous_system_phenotype | 1.53235257 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.43980599 |
| 38 | MP0000955_abnormal_spinal_cord | 1.43056863 |
| 39 | MP0000604_amyloidosis | 1.42431031 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.41611196 |
| 41 | MP0000566_synostosis | 1.38747835 |
| 42 | MP0008260_abnormal_autophagy | 1.38411149 |
| 43 | MP0004134_abnormal_chest_morphology | 1.37625868 |
| 44 | MP0003633_abnormal_nervous_system | 1.36053714 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.35180568 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.34108353 |
| 47 | MP0008569_lethality_at_weaning | 1.32767136 |
| 48 | MP0001440_abnormal_grooming_behavior | 1.27617058 |
| 49 | MP0003195_calcinosis | 1.27283517 |
| 50 | MP0002063_abnormal_learning/memory/cond | 1.26499700 |
| 51 | MP0002066_abnormal_motor_capabilities/c | 1.24238329 |
| 52 | MP0001963_abnormal_hearing_physiology | 1.24206757 |
| 53 | MP0001970_abnormal_pain_threshold | 1.21325480 |
| 54 | MP0004147_increased_porphyrin_level | 1.20735212 |
| 55 | MP0002067_abnormal_sensory_capabilities | 1.17732631 |
| 56 | MP0002752_abnormal_somatic_nervous | 1.15467342 |
| 57 | MP0001346_abnormal_lacrimal_gland | 1.14928875 |
| 58 | MP0004924_abnormal_behavior | 1.14804212 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.14804212 |
| 60 | MP0005623_abnormal_meninges_morphology | 1.09584942 |
| 61 | MP0000747_muscle_weakness | 1.05195472 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.05114574 |
| 63 | MP0000647_abnormal_sebaceous_gland | 1.04362006 |
| 64 | MP0003938_abnormal_ear_development | 1.04306789 |
| 65 | MP0005195_abnormal_posterior_eye | 1.00723281 |
| 66 | MP0001851_eye_inflammation | 0.93654075 |
| 67 | MP0001177_atelectasis | 0.93330632 |
| 68 | MP0002733_abnormal_thermal_nociception | 0.92441784 |
| 69 | MP0001661_extended_life_span | 0.90984500 |
| 70 | MP0004145_abnormal_muscle_electrophysio | 0.90695498 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.89588467 |
| 72 | MP0000762_abnormal_tongue_morphology | 0.85246459 |
| 73 | MP0000026_abnormal_inner_ear | 0.83373677 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 0.82795503 |
| 75 | MP0002295_abnormal_pulmonary_circulatio | 0.81853989 |
| 76 | MP0002822_catalepsy | 0.81335691 |
| 77 | MP0002152_abnormal_brain_morphology | 0.79763527 |
| 78 | MP0001968_abnormal_touch/_nociception | 0.79041122 |
| 79 | MP0005408_hypopigmentation | 0.76866153 |
| 80 | MP0000579_abnormal_nail_morphology | 0.75737436 |
| 81 | MP0006082_CNS_inflammation | 0.75569809 |
| 82 | MP0005253_abnormal_eye_physiology | 0.74596084 |
| 83 | MP0001348_abnormal_lacrimal_gland | 0.72141862 |
| 84 | MP0002184_abnormal_innervation | 0.71069970 |
| 85 | MP0002735_abnormal_chemical_nociception | 0.70675600 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.68375030 |
| 87 | MP0001502_abnormal_circadian_rhythm | 0.67217306 |
| 88 | MP0006072_abnormal_retinal_apoptosis | 0.66766567 |
| 89 | MP0003137_abnormal_impulse_conducting | 0.65839801 |
| 90 | MP0004036_abnormal_muscle_relaxation | 0.64901477 |
| 91 | MP0000467_abnormal_esophagus_morphology | 0.62177538 |
| 92 | MP0000003_abnormal_adipose_tissue | 0.61970354 |
| 93 | MP0002736_abnormal_nociception_after | 0.61454535 |
| 94 | MP0002557_abnormal_social/conspecific_i | 0.61367439 |
| 95 | MP0008438_abnormal_cutaneous_collagen | 0.61032949 |
| 96 | MP0002133_abnormal_respiratory_system | 0.60783939 |
| 97 | MP0005388_respiratory_system_phenotype | 0.60783939 |
| 98 | MP0002090_abnormal_vision | 0.60607110 |
| 99 | MP0001340_abnormal_eyelid_morphology | 0.57912563 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.57675256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.95736132 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.95736132 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.28904890 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 5.13108470 |
| 5 | Parakeratosis (HP:0001036) | 4.95159944 |
| 6 | Peripheral hypomyelination (HP:0007182) | 4.63413602 |
| 7 | Cerebral inclusion bodies (HP:0100314) | 4.46184981 |
| 8 | Sensory axonal neuropathy (HP:0003390) | 4.41959841 |
| 9 | Onion bulb formation (HP:0003383) | 3.96789800 |
| 10 | Insidious onset (HP:0003587) | 3.78842754 |
| 11 | Termporal pattern (HP:0011008) | 3.78842754 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.72173774 |
| 13 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.70850859 |
| 14 | Cerebral hypomyelination (HP:0006808) | 3.67703969 |
| 15 | Spastic gait (HP:0002064) | 3.65464076 |
| 16 | Abnormal auditory evoked potentials (HP:0006958) | 3.49676606 |
| 17 | Alacrima (HP:0000522) | 3.25649221 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.16345645 |
| 19 | Intention tremor (HP:0002080) | 3.13669782 |
| 20 | Dysmetria (HP:0001310) | 3.12432538 |
| 21 | Ankle clonus (HP:0011448) | 3.04869826 |
| 22 | Retinal dysplasia (HP:0007973) | 3.04866507 |
| 23 | Leukodystrophy (HP:0002415) | 3.00901678 |
| 24 | Myokymia (HP:0002411) | 2.97732603 |
| 25 | Increased serum pyruvate (HP:0003542) | 2.93165216 |
| 26 | Abnormality of glycolysis (HP:0004366) | 2.93165216 |
| 27 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.87248384 |
| 28 | Slow saccadic eye movements (HP:0000514) | 2.85870235 |
| 29 | Scanning speech (HP:0002168) | 2.85098022 |
| 30 | Anteriorly placed anus (HP:0001545) | 2.81503356 |
| 31 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.69389973 |
| 32 | Absent septum pellucidum (HP:0001331) | 2.67332519 |
| 33 | Clumsiness (HP:0002312) | 2.58713169 |
| 34 | Hypoplastic pelvis (HP:0008839) | 2.58462250 |
| 35 | Stridor (HP:0010307) | 2.57424957 |
| 36 | Decreased lacrimation (HP:0000633) | 2.56482320 |
| 37 | Thickened helices (HP:0000391) | 2.56477225 |
| 38 | Premature skin wrinkling (HP:0100678) | 2.55380824 |
| 39 | Cerebral hemorrhage (HP:0001342) | 2.53211445 |
| 40 | Split foot (HP:0001839) | 2.51079236 |
| 41 | Autoamputation (HP:0001218) | 2.49646502 |
| 42 | CNS hypomyelination (HP:0003429) | 2.43156710 |
| 43 | Spastic paraparesis (HP:0002313) | 2.39795270 |
| 44 | Increased circulating renin level (HP:0000848) | 2.39410727 |
| 45 | Morphological abnormality of the inner ear (HP:0011390) | 2.39028306 |
| 46 | Metabolic alkalosis (HP:0200114) | 2.30826427 |
| 47 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.29322794 |
| 48 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.29144843 |
| 49 | Aplasia of the phalanges of the hand (HP:0009802) | 2.29144843 |
| 50 | Aplasia involving bones of the extremities (HP:0009825) | 2.29144843 |
| 51 | Abnormality of the septum pellucidum (HP:0007375) | 2.27572721 |
| 52 | Coronal craniosynostosis (HP:0004440) | 2.25604477 |
| 53 | Pheochromocytoma (HP:0002666) | 2.23527820 |
| 54 | White forelock (HP:0002211) | 2.22604974 |
| 55 | Lower limb muscle weakness (HP:0007340) | 2.22529311 |
| 56 | Akinesia (HP:0002304) | 2.22252209 |
| 57 | Patchy hypopigmentation of hair (HP:0011365) | 2.19694555 |
| 58 | Foot dorsiflexor weakness (HP:0009027) | 2.18016043 |
| 59 | Hypoplasia of the iris (HP:0007676) | 2.16054098 |
| 60 | Spastic tetraparesis (HP:0001285) | 2.14514263 |
| 61 | Axonal loss (HP:0003447) | 2.13043008 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.11668627 |
| 63 | Megalencephaly (HP:0001355) | 2.08855209 |
| 64 | Hypomagnesemia (HP:0002917) | 2.04407095 |
| 65 | Partial duplication of thumb phalanx (HP:0009944) | 2.04115827 |
| 66 | Hypokalemic alkalosis (HP:0001949) | 2.03937087 |
| 67 | Humeroradial synostosis (HP:0003041) | 2.02156830 |
| 68 | Synostosis involving the elbow (HP:0003938) | 2.02156830 |
| 69 | Decreased motor nerve conduction velocity (HP:0003431) | 2.01884153 |
| 70 | Muscle fiber splitting (HP:0003555) | 2.01396606 |
| 71 | Cupped ear (HP:0000378) | 2.01299121 |
| 72 | Hypophosphatemic rickets (HP:0004912) | 1.97380285 |
| 73 | Abnormality of the foot musculature (HP:0001436) | 1.97338174 |
| 74 | Partial agenesis of the corpus callosum (HP:0001338) | 1.96796937 |
| 75 | Renal Fanconi syndrome (HP:0001994) | 1.95030322 |
| 76 | Poor speech (HP:0002465) | 1.94152534 |
| 77 | Neuroendocrine neoplasm (HP:0100634) | 1.93135425 |
| 78 | Clonus (HP:0002169) | 1.92062300 |
| 79 | Methylmalonic acidemia (HP:0002912) | 1.91540652 |
| 80 | Infantile muscular hypotonia (HP:0008947) | 1.90473538 |
| 81 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.89146671 |
| 82 | Esophageal atresia (HP:0002032) | 1.86311235 |
| 83 | Bowel incontinence (HP:0002607) | 1.86032993 |
| 84 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85107823 |
| 85 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.84456065 |
| 86 | Action tremor (HP:0002345) | 1.84116018 |
| 87 | Urinary incontinence (HP:0000020) | 1.83740573 |
| 88 | Gowers sign (HP:0003391) | 1.83001506 |
| 89 | Choreoathetosis (HP:0001266) | 1.82374330 |
| 90 | Urinary urgency (HP:0000012) | 1.81617838 |
| 91 | Hammertoe (HP:0001765) | 1.81541696 |
| 92 | Paraparesis (HP:0002385) | 1.80425182 |
| 93 | Focal motor seizures (HP:0011153) | 1.78111646 |
| 94 | Abnormal large intestine physiology (HP:0012700) | 1.74081455 |
| 95 | Erythroderma (HP:0001019) | 1.72374098 |
| 96 | Partial duplication of the phalanx of hand (HP:0009999) | 1.70137394 |
| 97 | Distal sensory impairment (HP:0002936) | 1.70108687 |
| 98 | Adrenal hypoplasia (HP:0000835) | 1.69207441 |
| 99 | Diaphragmatic weakness (HP:0009113) | 1.67768873 |
| 100 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.66908027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.29152949 |
| 2 | OXSR1 | 4.55851319 |
| 3 | EPHB1 | 3.61097443 |
| 4 | PKN1 | 2.76747431 |
| 5 | PBK | 2.74475818 |
| 6 | MAPKAPK5 | 2.67575032 |
| 7 | BCR | 2.67317417 |
| 8 | CDK19 | 2.47053542 |
| 9 | WNK4 | 2.43414839 |
| 10 | MET | 2.36629883 |
| 11 | FGFR2 | 2.24203884 |
| 12 | WNK1 | 2.06302513 |
| 13 | TESK2 | 1.91811824 |
| 14 | LIMK1 | 1.91733705 |
| 15 | UHMK1 | 1.85264633 |
| 16 | TNIK | 1.75366535 |
| 17 | PNCK | 1.72860584 |
| 18 | CSNK1G3 | 1.71653945 |
| 19 | CAMK2B | 1.69923922 |
| 20 | CSNK1A1L | 1.66709789 |
| 21 | NEK6 | 1.63185432 |
| 22 | NTRK1 | 1.57576473 |
| 23 | MST4 | 1.50974333 |
| 24 | ROCK2 | 1.49777821 |
| 25 | ICK | 1.44252706 |
| 26 | CLK1 | 1.43615001 |
| 27 | FGR | 1.42964088 |
| 28 | CAMK2D | 1.39589555 |
| 29 | CSNK1G1 | 1.35400214 |
| 30 | CASK | 1.33814379 |
| 31 | CSNK1G2 | 1.26466109 |
| 32 | SGK223 | 1.23577393 |
| 33 | SGK494 | 1.23577393 |
| 34 | PAK6 | 1.21648906 |
| 35 | EPHA4 | 1.14299242 |
| 36 | CAMK2G | 1.09648574 |
| 37 | PRPF4B | 1.08287684 |
| 38 | MUSK | 1.03806381 |
| 39 | DYRK2 | 0.99777571 |
| 40 | MARK1 | 0.97154460 |
| 41 | TYRO3 | 0.91331926 |
| 42 | CAMK2A | 0.88216495 |
| 43 | MARK2 | 0.85183710 |
| 44 | CDK5 | 0.83211141 |
| 45 | CDK14 | 0.82145672 |
| 46 | PAK3 | 0.81976502 |
| 47 | PRKCQ | 0.80101403 |
| 48 | MAPK15 | 0.77540624 |
| 49 | PRKD1 | 0.76509614 |
| 50 | CDK15 | 0.72622502 |
| 51 | PRKCE | 0.68557240 |
| 52 | CDK18 | 0.67313581 |
| 53 | ERBB4 | 0.67153043 |
| 54 | BMPR1B | 0.66510960 |
| 55 | IRAK2 | 0.64916863 |
| 56 | CDK11A | 0.64663372 |
| 57 | PHKG2 | 0.63960605 |
| 58 | PHKG1 | 0.63960605 |
| 59 | RPS6KA5 | 0.62938804 |
| 60 | ARAF | 0.62733107 |
| 61 | PDPK1 | 0.58233847 |
| 62 | FYN | 0.53656320 |
| 63 | CSNK1D | 0.51051715 |
| 64 | TRPM7 | 0.49754232 |
| 65 | PRKG1 | 0.48854103 |
| 66 | GSK3A | 0.48719615 |
| 67 | NTRK2 | 0.48650265 |
| 68 | MAPK13 | 0.46931149 |
| 69 | STK11 | 0.43433171 |
| 70 | CSNK1A1 | 0.43029282 |
| 71 | PRKACB | 0.42270179 |
| 72 | MAP3K13 | 0.42152385 |
| 73 | MKNK1 | 0.41616761 |
| 74 | MAP2K2 | 0.41596951 |
| 75 | KSR2 | 0.41023091 |
| 76 | FES | 0.38146549 |
| 77 | CAMK1G | 0.37027495 |
| 78 | PIK3CA | 0.37009654 |
| 79 | DMPK | 0.36872515 |
| 80 | PRKCH | 0.36751854 |
| 81 | PAK1 | 0.35894148 |
| 82 | ADRBK2 | 0.34865144 |
| 83 | PINK1 | 0.32979805 |
| 84 | BMX | 0.32910135 |
| 85 | MAPK7 | 0.32731231 |
| 86 | BMPR2 | 0.31669753 |
| 87 | PDGFRB | 0.31646036 |
| 88 | PTK2B | 0.30970947 |
| 89 | OBSCN | 0.30904518 |
| 90 | GRK7 | 0.30141555 |
| 91 | DAPK3 | 0.29836699 |
| 92 | PRKACA | 0.29734657 |
| 93 | INSR | 0.28148989 |
| 94 | DYRK1A | 0.26864418 |
| 95 | PRKD3 | 0.26430129 |
| 96 | PDK1 | 0.25197944 |
| 97 | ITK | 0.24292183 |
| 98 | CSNK1E | 0.23136165 |
| 99 | SGK1 | 0.22828916 |
| 100 | MAPK10 | 0.22587053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.36818111 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.58443560 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.50186275 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.30614458 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.19893865 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.16100450 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52874742 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03907307 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.02872611 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.94692517 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.85981224 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84333393 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84327891 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.83742011 |
| 15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.82315575 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.68493952 |
| 17 | Axon guidance_Homo sapiens_hsa04360 | 1.67694436 |
| 18 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.50838228 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.44037002 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39650160 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36057161 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.35712486 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35305882 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33439336 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27015901 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25851950 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12775968 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11822280 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.10559488 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08628609 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.06236260 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.05199063 |
| 33 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.91675661 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91221919 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88160900 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 0.86962412 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84757839 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84397190 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80699702 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 0.80496233 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78702852 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75380230 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72845886 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72486629 |
| 45 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71494038 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 0.71268520 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69183531 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68813056 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68734281 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68336708 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.67765834 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67157701 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66381583 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.65815193 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65253208 |
| 56 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64947962 |
| 57 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64756457 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64455090 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64132330 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63472030 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62943483 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61309914 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.60703103 |
| 64 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.59933420 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59616077 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.57111684 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57104525 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.57098537 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56449824 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55566822 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55550231 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55064858 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51712331 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49959871 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.47185076 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.47098795 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46409253 |
| 78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.46393503 |
| 79 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.42814066 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42262152 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.41413451 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.40723712 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39896536 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39638397 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38880174 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37430776 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37215602 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.36735504 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35558279 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32058766 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30234967 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.30004966 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29201858 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29059368 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28783229 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28557329 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.26660325 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.25985937 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25143792 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.24879068 |

